Healthcare Global Enterprises · NSE: HCG · BSE: 539787
Q4 FY22 results · Jan–Mar 2022
Healthcare Global Enterprises reported revenue from operations of ₹364.63 crore (up 22.3% from Q4 FY21) and net profit of ₹2.25 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 364.63 | 298.05 | +22.3% | 358.06 | +1.8% |
| Other income | 3.01 | 4.40 | −31.6% | 2.92 | +3.1% |
| Total income | 367.64 | 302.45 | +21.6% | 360.98 | +1.8% |
| Profit before tax | 0.92 | (105.23) | Turned profit | (46.13) | Turned profit |
| Net profit for the period | 2.25 | (113.76) | Turned profit | (49.80) | Turned profit |
| Attributable to shareholders of the company | 5.99 | (102.17) | Turned profit | (45.78) | Turned profit |
| EPS, basic (₹) | 0.43 | (8.14) | not comparable | (3.55) | Turned profit |
| Net margin (%) | 0.6 | -38.2 | -13.9 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 220.19 | 179.51 | +22.7% | 215.51 | +2.2% |
| Other income | 2.25 | 4.60 | −51.1% | 1.97 | +14.2% |
| Total income | 222.44 | 184.11 | +20.8% | 217.48 | +2.3% |
| Profit before tax | (15.73) | (150.66) | Loss narrowed | (37.86) | Loss narrowed |
| Net profit for the period | (17.92) | (153.22) | Loss narrowed | (39.13) | Loss narrowed |
| EPS, basic (₹) | (1.29) | (12.20) | not comparable | (3.03) | Loss narrowed |
| Net margin (%) | -8.1 | -85.4 | -18.2 |
Consolidated
- Filed with BSE
- 27 May 2022, 09:57 IST
- Board meeting
- 26 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2022, 09:57 IST
- Board meeting
- 26 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE